8-K: Current report filing
Published on December 9, 2022
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 9, 2022 (
(Exact name of registrant as specified in its charter) |
|
|
|||
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
||
(Address of principal executive offices) |
|
(Zip Code) |
( |
(Registrant’s telephone number, including area code) |
|
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.02 Unregistered Sales of Equity Securities; Item 3.03 Material Modification to Rights of Security Holders.
Senior Secured Convertible Redeemable Notes
On December 7, 2022, the Company approved the Amendments below to the senior secured convertible redeemable notes with Clayton Struve, extending the due dates to September 30, 2023.
Extension of Warrant Agreement
On December 7, 2022, the Company approved the Extension of Warrant Agreement with Clayton Struve, extending the exercise dates as follows:
Warrant No./Class |
Issue Date |
No. Warrant Shares |
Exercise Price |
Current Expiration Date |
Amended Expiration Date |
Clayton A. Struve Warrant |
08-14-2017 |
1,440,000 |
$0.25 |
08-13-2024 |
08-13-2025 |
Clayton A. Struve Warrant |
12-12-2017 |
1,200,000 |
$0.25 |
12-11-2024 |
12-11-2025 |
Clayton A. Struve Warrant |
08-04-2016 |
1,785,715 |
$0.25 |
08-04-2024 |
08-04-2025 |
Clayton A. Struve Warrant |
02-28-2018 |
1,344,000 |
$0.25 |
02-28-2024 |
02-28-2025 |
| 1 |
Item 9.01 Financial Statements and Exhibits.
Exhibits.
Exhibit No. |
|
Description of Exhibit |
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
104 |
|
Coverage Page Interactive Data File (embedded within the Inline XBRL document) |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 9, 2022 |
|
KNOW LABS, INC. |
|
|
|
|
|
|
|
/s/ Ronald P. Erickson |
|
|
Name: |
Ronald P. Erickson |
|
|
Title: |
Chairman of the Board |
|
| 3 |